A large IHC study performed on 4000 normal and neoplastic tissue samples, which included 79 different tumor categories, has shown that the over-expression of HOXD13 is prevalent in cancer tissues, compared to non-neoplastic samples, particularly in breast, colon and salivary glands cancers. Here, HOXD13 is linked to cancer.